ARTICLE | Clinical News
Jardiance empagliflozin regulatory update
December 8, 2014 8:00 AM UTC
Germany’s Institute for Quality and Efficiency in Healthcare (IQWiG) said in an early benefit assessment that the added benefit of Jardiance empagliflozin from Boehringer and Eli Lilly to treat Type I...